Return to content in this issue

Efficacy of Mepolizumab for the Treatment of Eosinophilic Cystitis: A Report of 2 Cases

Trefond L^1,2, Guy L³, Darcha C⁴, Gallon A⁵, Thomas-Monier R⁵, Berdugo K⁶, Smets P¹, Olagne L¹, Stievenart J¹, Fayard D¹, Cathebras P⁷, Aumaitre O^1,2, Boyer L⁵, Andre M^1,2, Kahn J-E<sup>6

1</sup>Service de Médecine Interne, CHU Gabriel Montpied, Clermont-Ferrand, France
²Université Clermont Auvergne, Inserm U1071, M2iSH, USCINRA1382, Clermont-Ferrand, France
³Service d’Urologie, CHU Gabriel Montpied, Clermont-Ferrand,France
⁴Service d’Anatomopathologie, CHU Estaing, Clermont Ferrand,France
⁵Service de Radiologie, CHU Gabriel Montpied, Clermont-Ferrand, France
⁶National Reference Center for Hypereosinophilic Syndromes,CEREO, Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris, Department of Internal Medicine, Ambroise ParéHospital, Boulogne-Billancourt, France
⁷Service de Médecine Interne, CHU de Saint-Étienne, SaintÉtienne, France

J Investig Allergol Clin Immunol 2024; Vol 34(3) : 202-204
doi: 10.18176/jiaci.0954